This small cap medical device maker's shares have surged on positive regulatory news

Anteris Technologies has won FDA approval to conduct a key clinical trial for its heart valve device in the US.
Proactive Investors

FDA clears Anteris to begin PARADIGM global pivotal trial of...

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has received US Food and Drug Administration (FDA) approval to initiate PARADIGM, a ...
Proactive Investors

Inside Biotech: Clinical progress puts Anteris’ next-gen heart valve on the radar

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) is making steady progress towards the next phase of clinical testing for its biomimetic heart ...
Stockhead on MSN

Lunch Wrap: ASX ruffled by hot CPI surprise, CSL dumps again

The ASX was coasting along nicely early doors today … before the inflation numbers hit like a brick through a windscreen.
Proactive Investors

The Market Wrap: ASX takes a hit as inflation numbers bring stocks down but small caps buck the trend

The S&P/ASX 200 fell 0.96% (-86.30) to 8,926.20, slipping below its 20-day moving average. Droneshield Ltd and Austal Ltd were the weakest performers, ...
Le Lézard

FDA Approves Anteris's DurAVR® THV Global Pivotal Trial (the "PARADIGM Trial")

Anteris announced today it has received U.S. Food and Drug Administration (FDA) approval to initiate PARADIGM, its global Investigational Device Exemption (IDE) clinical trial which is designed to ...

Telangana DGP advises CID Dept. to focus on emerging crime trends

Director General of Police, Telangana, B. Shivadhar Reddy, today advised the CID to focus on emerging crime trends and take special preventive measures.